Bioproperty, biomedicine and deliberative governance : patents as discourse on life
著者
書誌事項
Bioproperty, biomedicine and deliberative governance : patents as discourse on life
（Globalization and law / series editors, John Brainthwaite and Peter Drahos）
Ashgate, c2014
- : hbk
大学図書館所蔵 件 / 全2件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references (p. [181]-192) and index
内容説明・目次
内容説明
Biomedical patents have been the subject of heated debate. Regulatory agencies such as the European Patent Office make small decisions with big implications, which escape scrutiny and revision, when they decide who has access to expensive diagnostic tests, whether human embryonic stem cells can be traded in markets, and under what circumstances human health is more important than animal welfare. Moreover, the administration of the Trade Related Aspects of Intellectual Property Rights by the World Trade Organization has raised considerable disquiet as it has arguably created grave health inequities. Those doubting the merits of the one size fits all approach ask whether priority should be given to serving the present needs of populations in dire need of medication or to promoting global innovation. The book looks in detail into the legal issues and ethical debates to ask the following three main questions: First, what are the ideas, goals, and broader ethical visions that underpin questions of governance and the legal reasoning employed by administrative agencies? Second, how can we democratize the decision making process of technocratic institutions such as the European Patent Office? Finally, how can we make the global intellectual property system more equitable? In answering these questions the book seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms, and proposes ways to rethink the reform of the patent system through the lens of legitimacy.
目次
- Chapter 1 Introduction Patents as Discourse on Life: The Purposes of Patents in the Field of Biotechnology and Biomedical Innovation
- Part I The European Patent Office and the Question of Legitimacy: Morality, Ethics and Technocracy
- Chapter 2 The European Patent Office, Biotechnology and Ethics: Revising Ends of Policy and Rethinking Public Deliberation
- Chapter 3 Neutral or Practically Wise Regulator? Genes, Patents and Human Health
- Chapter 4 Rethinking Multilevel Governance in the EU and the Future of the EPO: From Morality to Ethics
- Part II Patents and Public Bioethics
- Chapter 5 Public Bioethics: Lay Opinions, and Human Need: From Sex Selection to Enhancement
- Chapter 6 EPO and Public Bioethics: Germ Line Interventions in Human Embryos, the Problem of Commodification and the Question of Incentives
- Part III Patents, Global Trade and Bioethics: Rethinking Good Governance
- Chapter 7 TRIPs, Access to Medicines and the Global Governance of Patents: Cultivating Humanity and Equity
- Chapter 8 Global Health Networks and Discursive Legitimacy
- Chapter 9 Some Reflections on Good Patent Governance
- Chapter 10 Conclusions: A Discursive Analysis of Patents
「Nielsen BookData」 より